Daiwa Securities Group Inc. Has $15.85 Million Holdings in Cardinal Health, Inc. $CAH

Daiwa Securities Group Inc. cut its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 77,147 shares of the company’s stock after selling 4,212 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Cardinal Health were worth $15,854,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Versor Investments LP purchased a new stake in Cardinal Health during the third quarter valued at about $2,090,000. Nordea Investment Management AB raised its position in Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after purchasing an additional 494,731 shares in the last quarter. Candriam S.C.A. raised its position in Cardinal Health by 10.8% during the third quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock valued at $30,790,000 after purchasing an additional 19,155 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of Cardinal Health by 44.9% during the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after buying an additional 707,495 shares during the last quarter. Finally, Public Sector Pension Investment Board grew its stake in shares of Cardinal Health by 66.7% during the third quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock valued at $4,710,000 after buying an additional 12,003 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

NYSE CAH opened at $205.79 on Friday. The stock has a market capitalization of $48.20 billion, a PE ratio of 31.47, a PEG ratio of 1.10 and a beta of 0.52. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The business’s 50-day moving average is $202.53 and its 200 day moving average is $208.57.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period last year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is 31.19%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CAH. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. JPMorgan Chase & Co. reduced their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. UBS Group set a $260.00 price objective on Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Argus raised their price objective on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Finally, William Blair began coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.